Free Trial
OTCMKTS:RDSMY

Koninklijke DSM (RDSMY) Stock Price, News & Analysis

$33.85
+1.08 (+3.30%)
(As of 11/11/2022)
Today's Range
$33.11
$33.90
50-Day Range
$33.85
$33.85
52-Week Range
$26.59
$56.92
Volume
56,500 shs
Average Volume
116,034 shs
Market Capitalization
$23.67 billion
P/E Ratio
N/A
Dividend Yield
1.09%
Price Target
N/A
RDSMY stock logo

About Koninklijke DSM Stock (OTCMKTS:RDSMY)

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

RDSMY Stock Price History

RDSMY Stock News Headlines

Downing Strate. Share Chat
You're missing out on these earnings plays
FREE Guide: Unlock Earnings Season's Hidden Profits 15+ years of trading wisdom condensed into one powerful strategy. Learn to spot opportunities others miss during Q3 earnings. Daily intel included: Morning briefing, Midday update, Evening report. Claim your free Ultimate Strategy Guide To Trade Earnings Season now.
Koninklijke DSM N.V. (DSM.DE)
Koninklijke DSM NV DSM
DSM2.BE - Koninklijke DSM NV
UBS maintains Koninklijke DSM at Buy
You're missing out on these earnings plays
FREE Guide: Unlock Earnings Season's Hidden Profits 15+ years of trading wisdom condensed into one powerful strategy. Learn to spot opportunities others miss during Q3 earnings. Daily intel included: Morning briefing, Midday update, Evening report. Claim your free Ultimate Strategy Guide To Trade Earnings Season now.
Koninklijke DSM N.V. (DSM.AS)
Koninklijke DSM N.V.
Royal DSM: DSM - delivery of shares
DSM - delivery of shares
Koninklijke DSM NV (0NPP)
See More Headlines
Receive RDSMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Koninklijke DSM and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2020
Today
7/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Current Symbol
OTCMKTS:RDSMY
Previous Symbol
NASDAQ:RDSMY
Employees
21,358
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.89 billion
Cash Flow
$2.29 per share
Book Value
$11.78 per share

Miscellaneous

Free Float
N/A
Market Cap
$23.67 billion
Optionable
Not Optionable
Beta
1.00
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Dimitri de Vreeze (Age 55)
    Co-CEO, COO & Member of the Managing Board
    Comp: $2.03M
  • Ms. Geraldine Matchett (Age 50)
    Co-CEO, CFO, Member of the Managing Board & Acting EVP of People & Organization
    Comp: $1.98M
  • Mr. Dave Huizing
    VP of Investor Relations
  • Ms. Lieke de Jong-Tops
    Sr. Communications Mang.
  • Mr. Rob J. Atsma (Age 76)
    Head of Energie Beheer Nederland
  • Mr. Paul Gilgen (Age 77)
    Head of Manufacturing & Purchasing of DSM Nutritional Products
  • Mr. Manfred Eggersdorfer (Age 71)
    Sr. VP of Nutrition Science & Advocacy
  • Mr. Bruno Müller (Age 66)
    Head of Strategy & VITAL Project - Nutritional Products
  • Mr. Jan Wolters (Age 79)
    Head of Fine Chemicals
  • Mr. Luca Rosetto (Age 59)
    Sr. VP of Operations - Nutritional Products

Should I Buy Koninklijke DSM Stock? RDSMY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Koninklijke DSM:

  • Koninklijke DSM operates in the nutrition, health, and sustainable living sectors, which are growing industries with increasing demand globally.
  • The company offers a diverse range of products in its Nutrition segment, including vitamins, probiotics, and specialty food enzymes, catering to various consumer needs.
  • DSM's Materials segment provides specialty plastics used in multiple industries, such as automotive and consumer goods, indicating a broad market reach.
  • DSM's Innovation Center focuses on biomedical materials and medical device technologies, showcasing a commitment to innovation and potential for future growth.
  • Considering the current stock price of Koninklijke DSM, which has shown stability and growth over recent periods, it presents a potential investment opportunity.

Cons

Investors should be bearish about investing in Koninklijke DSM for these reasons:

  • The company operates in the chemicals and allied products industry, which can be subject to regulatory challenges and environmental concerns, impacting its operations.
  • Global economic fluctuations may affect DSM's business performance, especially in regions where it has significant operations, leading to potential revenue volatility.
  • Competition in the nutrition and health sectors is intense, with other major players vying for market share, potentially affecting DSM's profitability.
  • Market trends and consumer preferences in sustainable living products may change rapidly, requiring continuous innovation and investment from DSM to stay competitive.
  • Investors should carefully monitor industry trends and DSM's financial performance to make informed decisions due to the inherent risks associated with investing in the stock market.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, July 1, 2024. Please send any questions or comments about these Koninklijke DSM pros and cons to contact@marketbeat.com.

RDSMY Stock Analysis - Frequently Asked Questions

How have RDSMY shares performed this year?

Koninklijke DSM's stock was trading at $33.85 at the beginning of 2024. Since then, RDSMY stock has increased by 0.0% and is now trading at $33.85.
View the best growth stocks for 2024 here
.

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) released its earnings results on Tuesday, November, 3rd. The basic materials company reported $0.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by $0.01. The basic materials company earned $2.29 billion during the quarter.
Read the conference call transcript
.

How do I buy shares of Koninklijke DSM?

Shares of RDSMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RDSMY) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners